Company Overview
- Headquarters
- 329 Oyster Point Blvd, South San Francisco CA
- Website
- acelot.com
- Phone
- (805) 680-1244
- Employees
- 16
- Founded in
- 2006
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 54171 CompaniesNAICS Code 5417 CompaniesNAICS Code 541714 CompaniesNAICS Code 54 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 873 CompaniesSIC Code 87 Companies
Financials & Stats
Revenue
$0B
Who is Acelot
Acelot is a privately held company located in South San Francisco, California. The company employs 16 people and has generated $405,000 in revenue. Acelot focuses on developing treatments for functional protein misfolding diseases. These diseases, which include ALS, FTD, Parkinson's, diabetes, and cancer, are characterized by the presence of misfolded proteins. Acelot's platform utilizes generative AI, molecular dynamics simulations, and proprietary assays to identify small molecules that can restore the normal function of these misfolded proteins. The company's platform was invented by Dr. Ambuj Singh, a Professor of Computer Science at the University of California, Santa Barbara. Acelot's lead candidate, ACE-2223, is an orally bioavailable small molecule designed to disrupt the misfolded forms of TDP43, a protein implicated in ALS, FTD, and Alzheimer's disease. ACE-2223 aims to restore functional TDP43 and has demonstrated promising brain penetrance and ADME properties. Acelot's website can be accessed at acelot.com.
Acelot Industry Tags
Acelot Tech Stack
Companies Similar to Acelot
Analyze industry trends and opportunities by examining competitors and companies comparable to Acelot, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
0M | 1 | Kentwood, MI | ||
0M | 2 | San Diego, CA | 2007 | |
Port Washington, NY | ||||
663 | Burlington, NJ | 1815 | ||
863 | Boston, MA | 2017 |